Literature DB >> 1195059

Pulmonary oedema in rats given dehydromonocrotaline: a topographic and electron-microscope study.

J V Hurley, M V Jago.   

Abstract

Study of cleared, histological and electron-microscope specimens shows that increased vascular permeability plays a major role in the formation of the pulmonary oedema and pleural effusions that occur in rats following the intravenous injection of a large dose of dehydromonocrotaline. There is a latent interval of 6-8 hr between injection of the dehydroalkaloid and the start of increased permeability which appears to be due to a direct damaging effect of the toxin on the endothelium of pulmonary capillaries and small venules. The endothelial injury does not cause permanent disruption of small blood vessels, and 2 days after injury all vessels are patent and lined by a complete layer of endothelium. Large numbers of mononuclear cells are present in the interstitial tissues of the lung 44 hr after injury. These cells appear to be emigrated blood monocytes but the cause of their emigration and their role in the subsequent progression of this type of injury to the lung are not clear.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1195059     DOI: 10.1002/path.1711170104

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  3 in total

1.  Hypertrophy of pulmonary arteries and arterioles with cor pulmonale in rats induced by seneciphylline, a pyrrolizidine alkaloid.

Authors:  K Ohtsubo; Y Ito; M Saito; T Furuya; M Hikichi
Journal:  Experientia       Date:  1977-04-15

2.  The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells.

Authors:  J F Reindel; R A Roth
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

3.  Ethchlorvynol-induced pulmonary edema in rats. An ultrastructural study.

Authors:  R Wysolmerski; D Lagunoff; T Dahms
Journal:  Am J Pathol       Date:  1984-06       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.